KDM2B and breast cancer: Nevertheless, another study revealed that FBXL10 knockdown triggered a more aggressive phenotype in breast cancer, and mechanism investigation demonstrated that FBXL10 acted as a tumor suppressor through regulating ribosome biogenesis and protein synthesis [45].